Development of a Mucoadhesive Liquid Crystal System for the Administration of Rifampicin Applicable in Tuberculosis Therapy

Since 1966, rifampicin (RIF) has been considered one of the most potent drugs in the treatment of tuberculosis (TB), which is caused by infection with M. tuberculosis (Mtb). New nanostructured formulations for RIF delivery and alternative routes of administration have been studied as potential forms...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Kaio Pini, Rodero, Camila Fernanda, Ribeiro, Camila Maríngolo, Gremião, Maria P. D., Peccinini, Rosângela Gonçalves, Pavan, Fernando Rogerio, Pearce, Camron, Gonzalez-Juarrero, Mercedes, Chorilli, Marlus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409883/
https://www.ncbi.nlm.nih.gov/pubmed/36013317
http://dx.doi.org/10.3390/life12081138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409883/
https://www.ncbi.nlm.nih.gov/pubmed/36013317
http://dx.doi.org/10.3390/life12081138

Ejemplares similares